Benefit of cosmetic injectables, in a cream?
Canadian innovation to begin research with support from the Government
VIDEO B-ROLL AVAILABLE
TORONTO, Sept. 10, 2012 /CNW/ – The following video is available by
satellite or by CNW’s Video On-Demand web download:
At the unveiling today of a new research facility, the government of
Canada announced they are investing funds into the further development
of Delivra. Thanks to this investment, Delivra Inc. an innovative
bio-medical research company will conduct new research in its
laboratory at the National Research Council of Canada Industrial
Partnership Facility in Charlottetown, P.E.I.
Through research spanning over six years, Canadian scientist Dr. Joseph
Gabriele has worked to develop Delivra, the groundbreaking transdermal
delivery system that transports active ingredients through the skin to
joints, muscles and other tissues, that, to date, no other topical
creams have been able to reach.
As a result, this innovation has been incorporated into Delivra’s new
line of topical pain relief creams LivRelief, which stands miles apart
from the efficacy of other over-the-counter creams.
According to newly released findings from the Canadian Pain Management
Report, a study commissioned by Delivra Inc., a staggering 90 per cent
of Canadians have purchased pain medication or treatments last year
alone. The survey was conducted on the Angus Reid Forum in August
Results in clinical testing have been unprecedented. The Delivra base in
LivRelief products is almost 700 per cent more effective in penetrating
deep through the skin – no other topical pain cream in the world can
provide such relief deep within the body. Other results include:
-- An absorption rate that is six times stronger than its competitors -- Addresses five of the 11 pain pathways in the body, compared to other current topical pain relief creams which only target one pain pathway -- Safe for use on children
Revered Canadian hockey legend Bobby Orr has said it had become a norm
for him to live with pain. LivRelief has greatly improved his quality
Other applications for Delivra show great potential for health and
beauty products, supplements, medications and anti-aging. In the
future, Delivra may be able to provide the same anti-aging benefits in
a topical cream that people can only get from cosmetic injectables
There are a multitude of potential applications for this technology,
with global implications.
Footage of adults experiencing pain, taking oral medication, applying
Laboratory footage and unveiling at the National Research Council of
Canada Industrial Partnership Facility in PEI
Footage of Bobby Orr playing hockey
Graphic: Canadian Pain Management Report by Delivra: findings
Dr. Joseph Gabriele, President and Chief Scientific Officer, Delivra
Bobby Orr, Hall of Famer and former NHL player
The Honourable Gary Goodyear, Minister of State for Science and
Technology and the Federal Economic Agency for Southern Ontario
The Honourable Robert Ghiz, Premier of Prince Edward Island
The following B-roll is available at the listed times and coordinates:
DATE OF FEED: Monday September 10, 2012 TIME OF FEED: 1:30 PM EST COORDINATES: GALAXY 3C K06 Slot A (18MHz) Downlink: 11805.5000 H Symbol Rate: 15.00 Ms Modulation: DVB S2 8PSK FEC: ¾ Date Rate: 32.6628
WEB Video Preview and Download link:
TIME OF POSTING: Approximately 3:00 PM EST DATE OF POSTING: Monday September 10, 2012
All video can be viewed by clicking on the link. Broadcast quality video
is available for download by accredited journalists. Please contact firstname.lastname@example.org for access.
STATIONS, FOR FURTHER INFORMATION:
Keka DasGupta at email@example.com or at 416 972 7727.
For technical information DURING the feed, or for assistance with Video
On-Demand, please contact CNW at firstname.lastname@example.org or (416) 863-5612.
CNW Video On-Demand http://cnw.pathfireondemand.com provides free, secure and easy-to-use broadcast quality material direct
from our website to accredited journalists worldwide.
SOURCE CNW Broadcast Services